Overview

Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.

Status:
Terminated

Trial end date:
2004-02-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the Safety, Tolerability and Efficacy of ZD6126 in Combination with Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects with Metastatic Colorectal Cancer.

Phase:

Phase 2

Details

Lead Sponsor:

AstraZeneca

Treatments:

Fluorouracil
Leucovorin
Oxaliplatin